Bioventix PLC (LON:BVXP - Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 3,184.98 ($42.36) and traded as low as GBX 2,460 ($32.72). Bioventix shares last traded at GBX 2,493 ($33.16), with a volume of 18,396 shares traded.
Bioventix Stock Performance
The company has a market capitalization of £135.44 million, a price-to-earnings ratio of 16.73 and a beta of 0.35. The company has a 50-day moving average price of GBX 2,665.01 and a 200-day moving average price of GBX 3,153.14.
Bioventix (LON:BVXP - Get Free Report) last issued its earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.96) EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. As a group, sell-side analysts anticipate that Bioventix PLC will post 166.3066955 earnings per share for the current fiscal year.
Bioventix Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Friday, April 25th. Investors of record on Thursday, April 10th were paid a dividend of GBX 70 ($0.93) per share. This represents a yield of 2.95%. The ex-dividend date was Thursday, April 10th. Bioventix's payout ratio is presently 102.19%.
About Bioventix
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
See Also
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
